A Study of the Pharmacokinetics, Safety and Tolerability of Topiramate in Infants (Age 1-24 Months) With Refractory Partial-Onset Seizures

This study has been completed.

Study NCT00233012 Information provided by Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

First Received: October 3, 2005 Last Updated: January 28, 2008 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Study Completion Date:	October 2007
Estimated Primary Completion Date:	No date given